Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers
Kaifeng Liu, Meijia Li, Yudong Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Model-informed precision dosing: State of the art and future perspectives
Iris K. Minichmayr, Erwin Dreesen, Marco Centanni, et al.
Advanced Drug Delivery Reviews (2024) Vol. 215, pp. 115421-115421
Open Access | Times Cited: 10
Antibody-Drug Conjugates in Urothelial Cancer: From Scientific Rationale to Clinical Development
Whi‐An Kwon, Seo Yeon Lee, Tae Cheon Jeong, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2420-2420
Open Access | Times Cited: 5
Imaged Capillary Isoelectric Focusing Coupled to High‐Resolution Mass Spectrometry (icIEF‐MS) for Cysteine‐Linked Antibody–Drug Conjugate (ADC) Heterogeneity Characterization Under Native Condition
Xiaoxi Zhang, Gang Wu, Min Du, et al.
Electrophoresis (2024)
Closed Access | Times Cited: 5
Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer
Julia S. Hillmann, Nicolaì Maass, Dirk Bauerschlag, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Challenges and Insights in Absolute Quantification of Recombinant Therapeutic Antibodies by Mass Spectrometry: An Introductory Review
Sarah Döring, Michael G. Weller, Yvonne Reinders, et al.
Antibodies (2025) Vol. 14, Iss. 1, pp. 3-3
Open Access
What are biopharmaceuticals?
Abhay H. Pande, Yenisetti Rajendra Prasad, J. Anakha
(2025)
Closed Access
Immunotherapy in Recurrent Ovarian Cancer
Keyao Chen, Jingjing Wang, Meng Yang, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 168-168
Open Access
Monitoring and management of adverse effects associated with trastuzumab deruxtecan: a UAE-specific consensus
Emad Dawoud, Fathi Azribi, Aref Chehal, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
The validation and clinical bioanalysis of the Bicycle® Toxin Conjugate zelenectide pevedotin in human plasma
Joseph Tweed, Fern Adams-Dam, Justin Bader, et al.
Bioanalysis (2025), pp. 1-9
Closed Access
Detection of anti-drug antibodies against antibody-drug conjugates by solid-phase extraction with acid dissociation in cynomolgus monkey serum
Susan Chen, Konstantin Piatkov, Linlin Dong, et al.
Drug Metabolism and Disposition (2025) Vol. 53, Iss. 3, pp. 100039-100039
Open Access
Modular Synthesis of Anti-HER2 Dual-Drug Antibody-Drug Conjugates Demonstrating Improved Toxicity
Christine S. Nervig, M. S. Rice, Marcello Marelli, et al.
Bioconjugate Chemistry (2025)
Closed Access
An Affibody-Cytotoxin Conjugate-Based Nanoagent for EGFR Targeting and Precise Therapy of Epidermal Squamous Cell Carcinoma
Xiaoyuan Yang, Xuelin Xia, Qingrong Li, et al.
ACS Applied Nano Materials (2025)
Closed Access
Molecular Dynamics (MD)-Derived Features for Canonical and Noncanonical Amino Acids
Tiffani Hui, Maxim Secor, Minh Ngoc Ho, et al.
Journal of Chemical Information and Modeling (2025)
Open Access
Global research progress in antibody-drug conjugates for solid tumors: Bibliometrics and visualized analysis
Wenjun Fang, Xueqing Ma, Ben Liu
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Comprehensive Overview on Antibody Drug Conjugates- A Promising Approach in Cancer Therapy
Lenna Muppa, Shruthi Ravindranathan, Sudha Sivaram, et al.
Journal of Drug Delivery and Therapeutics (2025) Vol. 15, Iss. 3, pp. 125-132
Open Access
PK/PD of Positively Charged ADC in Mice
Hsuan‐Ping Chang, Huyen Khanh Le, Shufang Liu, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 377-377
Open Access
Antibody drug conjugates integrated with lipid nanocarrier for cancer theranostics
B. Rajesh Kumar, Akash Shukla, Nazeer Ahmed, et al.
Elsevier eBooks (2025), pp. 333-363
Closed Access
Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert Opinion
Navid Sobhani, Alberto D’Angelo, Matteo Pittacolo, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3089-3089
Open Access | Times Cited: 3
Comparative analysis of FDA approvals by top 20 pharma companies (2014–2023)
Alexander Schuhmacher, Oliver Gassmann, Markus Hinder, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104128-104128
Open Access | Times Cited: 2
Bispecific Antibodies, Immune Checkpoint Inhibitors, and Antibody−Drug Conjugates Directing Antitumor Immune Responses: Challenges and Prospects
C. Li, Xin Yuan, Ping Yi
Cell Biochemistry and Function (2024) Vol. 42, Iss. 8
Open Access | Times Cited: 2
Multiepitope recognition technology promotes the in-depth analysis of antibody‒drug conjugates
Yutian Lei, Yuan Shen, Feng Chen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4962-4976
Open Access | Times Cited: 1
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer
Sho Sato, Tadahiro Shoji, Ami Jo, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2545-2545
Open Access | Times Cited: 1
Antibody-drug conjugates for hepato-pancreato-biliary malignancies: “Magic bullets” to the rescue?
Charalampos Theocharopoulos, Ioannis A. Ziogas, Charalampos-Christos Douligeris, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102806-102806
Closed Access | Times Cited: 1
Targeted Drug Conjugates in Cancer Therapy: Challenges and Opportunities
Geng Jia, Yuqi Jiang, Xiaoyang Li
Pharmaceutical Science Advances (2024) Vol. 2, pp. 100048-100048
Open Access | Times Cited: 1
Future AI Will Be Able to Predict Antibody-Drug Conjugate Response in Oncology
Navid Sobhani, Alberto D’Angelo, Matteo Pittacolo, et al.
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top